Zhao, H., Yu, X., Ding, Y., Zhao, J., Wang, G., Wu, X., . . . Cui, S. (2016). MiR-770-5p inhibits cisplatin chemoresistance in human ovarian cancer by targeting ERCC2. Oncotarget.
Chicago Style CitationZhao, Henan, et al. "MiR-770-5p Inhibits Cisplatin Chemoresistance in Human Ovarian Cancer By Targeting ERCC2." Oncotarget 2016.
Cita MLAZhao, Henan, et al. "MiR-770-5p Inhibits Cisplatin Chemoresistance in Human Ovarian Cancer By Targeting ERCC2." Oncotarget 2016.
Atenció: Aquestes cites poden no estar 100% correctes.